Page last updated: 2024-08-24

duloxetine hydrochloride and Acute Liver Injury, Drug-Induced

duloxetine hydrochloride has been researched along with Acute Liver Injury, Drug-Induced in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's7 (53.85)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, YA; Dong, J; Li, R; Li, T; Li, Z; Liu, J; Wang, Q; Wang, Y; Xue, R; Zhang, T; Zhang, Y; Zhuang, X1
Jiao, X; Li, Y; Liang, M; Tang, B; Wang, X; Xiao, Y; Xie, X1
Cunningham, EA; Kassam, AS; Musco, SE1
Chang, CL; Dore, DD; Li, H; Lin, ND; Norman, H; Perahia, DG; Regev, A1
Acharya, N; Heinloth, AN; Kuritzky, L; Regev, A; Robinson, M; Strombom, I; Wernicke, JF; Wohlreich, MM1
Acharya, N; D'Souza, DN; DiPietro, N; Gahimer, JL; Strombom, I; Uetrecht, JP; Wernicke, J1
Acharya, N; D'Souza, DN; Seeger, J; Strombom, I; Wernicke, JF1
D'Souza, DN; Henck, JW; Knadler, MP; Murray, I; Pangallo, B; Uetrecht, JP; Wang, F; Wernicke, J1
Fernandez-Fernandez, FJ; Fuente-Aguado, Jde L; Montero-Tinnirello, J; Rodriguez-Pecci, MS1
Bonkovsky, H; Chalasani, N; Fontana, RJ; Hayashi, PH; Hoofnagle, JH; Kleiner, D; Saxena, R; Vuppalanchi, R1
Seeger, JD; Strombom, I; Turnbull, B; Xue, F; Zhu, S1
Ammar, H; Malani, AK1

Reviews

3 review(s) available for duloxetine hydrochloride and Acute Liver Injury, Drug-Induced

ArticleYear
Answers to the most common questions about the hepatic safety profile of duloxetine.
    Postgraduate medicine, 2008, Volume: 120, Issue:2

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Drug Approval; Drug Labeling; Duloxetine Hydrochloride; Humans; Liver Diseases; Risk Assessment; Thiophenes; United States

2008
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Age Distribution; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Child; Consumer Product Safety; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sex Distribution; Thiophenes; Young Adult

2008
Hepatic effects of duloxetine-I: non-clinical and clinical trial data.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Consumer Product Safety; Drug Evaluation, Preclinical; Duloxetine Hydrochloride; Humans; Liver; Liver Diseases; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Species Specificity; Thiophenes

2008

Other Studies

10 other study(ies) available for duloxetine hydrochloride and Acute Liver Injury, Drug-Induced

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
High-content imaging of human hepatic spheroids for researching the mechanism of duloxetine-induced hepatotoxicity.
    Cell death & disease, 2022, 08-01, Volume: 13, Issue:8

    Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder, Major; Duloxetine Hydrochloride; Fatty Liver; Humans

2022
Evaluating Drug-Induced Liver Injury and Its Remission via Discrimination and Imaging of HClO and H
    Analytical chemistry, 2018, 06-19, Volume: 90, Issue:12

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Duloxetine Hydrochloride; Fluorescent Dyes; Fluoxetine; Humans; Hydrogen Sulfide; Hypochlorous Acid; Molecular Structure; Optical Imaging; Protons

2018
Dangers of Rapid Dosing: A Case of Dose-Dependent Drug-Induced Liver Injury From Duloxetine.
    The primary care companion for CNS disorders, 2019, Mar-21, Volume: 21, Issue:2

    Topics: Adult; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Mental Disorders

2019
Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
    BMC gastroenterology, 2015, Oct-14, Volume: 15

    Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Depression; Drug Utilization Review; Duloxetine Hydrochloride; Female; Humans; Incidence; Insurance, Health; Male; Middle Aged; Propensity Score; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; United States; Venlafaxine Hydrochloride; Young Adult

2015
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Consumer Product Safety; Cyclohexanols; Databases as Topic; Duloxetine Hydrochloride; Humans; Liver; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride

2008
[Mirtazapine-associated hepatotoxicity].
    Medicina clinica, 2010, Nov-06, Volume: 135, Issue:13

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Drug Interactions; Duloxetine Hydrochloride; Humans; Kidney Failure, Chronic; Male; Mianserin; Middle Aged; Mirtazapine; Nephrosclerosis; Thiophenes

2010
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
    Alimentary pharmacology & therapeutics, 2010, Volume: 32, Issue:9

    Topics: Adult; Antidepressive Agents; Biopsy; Chemical and Drug Induced Liver Injury; Duloxetine Hydrochloride; Female; Humans; Liver; Male; Middle Aged; Prospective Studies; Thiophenes

2010
Duloxetine for depression and the incidence of hepatic events in adults.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cohort Studies; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Thiophenes; Young Adult

2011
Medical management of depression.
    The New England journal of medicine, 2006, Feb-09, Volume: 354, Issue:6

    Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder; Duloxetine Hydrochloride; Humans; Liver Function Tests; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiophenes; Triazoles

2006